Lethal infections in patients with hematological malignancies

Area of Science:

• Hematology
• Infectious Diseases
• Oncology

Background:

• Infections pose a significant threat to patients with hematological malignancies.
• Understanding infection as a cause of death is crucial for improving patient outcomes.

Purpose of the Study:

• To determine the significance of infections as a cause of death in patients with hematological malignancy.
• To analyze the types and trends of infections, particularly fungal infections, in this patient population.

Main Methods:

• Retrospective review of hospital files for 410 patients with hematological malignancy treated between 1977 and 1990.
• Analysis of infection documentation (microbiologically, clinically, possible), causative agents, and diagnostic timing.
• Comparison of C-reactive protein (CRP) concentrations between patients with verified infections and those who died of other causes.

Main Results:

• Infections accounted for 49.5% of deaths.
• Gram-negative bacteria (31.3%) and fungi (25.9%) were the most common causes of microbiologically documented infections.
• Systemic fungal infections were often diagnosed post-mortem (27/29), with an increasing trend observed after 1982 despite antifungal therapy.
• Patients with verified infections had significantly higher CRP levels (152 mg/l vs. 117.5 mg/l).

Conclusions:

• Infection is a significant cause of mortality in hematological malignancy patients.
• There is an increasing incidence of systemic fungal infections, necessitating enhanced diagnostic and therapeutic strategies.
• Improved diagnostic methods and more effective treatments are urgently required for fungal infections in this vulnerable group.